Pancreatic cystic neuroendocrine tumors: Preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology

Marshall S. Baker, Jamie L. Knuth, John DeWitt, Julia Leblanc, Harvey Cramer, Thomas Howard, C. Schmidt, Keith D. Lillemoe, Henry A. Pitt

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Pancreatic cystic neuroendocrine tumors (CNETs) are rare premalignant conditions. Computed tomography (CT) occasionally demonstrates the hypervascular border characteristic of NETs. Endoscopic ultrasound (EUS) with fine-needle aspiration and immunocytology may be a more consistent means to establish the diagnosis, but no data on the role of EUS are available. This report represents the largest series of CNETs treated to date, documents the role of EUS in preoperative diagnosis, and describes current management. Retrospective review of our experience with CNETs treated at an academic center between 1999 and 2006. Thirteen patients with CNETs were identified. One had symptoms consistent with a functional tumor; the others were nonfunctional. Twelve were detected by CT; only three had peripheral hypervascularity. Nine were studied with preoperative EUS/immunocytology; each of these demonstrated strong staining for chromogranin and synaptophysin. All were resected: four by pancreaticoduodenectomy, one by total pancreatectomy, and one by enucleation. Perioperative morbidity occurred in 39%. Perioperative mortality was 0%. Average follow-up was 3.3∈+∈0.5 years. One patient had late hepatic recurrence and ultimately died of disease. Two developed recurrent NET in the context of MEN I and required additional surgery. Twelve are alive with no evidence of disease. EUS-guided immunocytology with staining for neuroendocrine markers is an accurate method to establish the diagnosis of CNET preoperatively. Short- and long-term outcomes after resection are excellent.

Original languageEnglish
Pages (from-to)450-456
Number of pages7
JournalJournal of Gastrointestinal Surgery
Volume12
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

Neuroendocrine Tumors
Needles
Tomography
Staining and Labeling
Chromogranins
Multiple Endocrine Neoplasia Type 1
Synaptophysin
Pancreatectomy
Pancreaticoduodenectomy
Fine Needle Biopsy
Morbidity
Recurrence
Mortality
Liver
Neoplasms

Keywords

  • Chromogranin
  • Neuroendocrine tumors
  • Pancreatic cyst
  • Synaptophysin

ASJC Scopus subject areas

  • Surgery

Cite this

Pancreatic cystic neuroendocrine tumors : Preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology. / Baker, Marshall S.; Knuth, Jamie L.; DeWitt, John; Leblanc, Julia; Cramer, Harvey; Howard, Thomas; Schmidt, C.; Lillemoe, Keith D.; Pitt, Henry A.

In: Journal of Gastrointestinal Surgery, Vol. 12, No. 3, 03.2008, p. 450-456.

Research output: Contribution to journalArticle

@article{7fb40e3ef6b54329ad0498e45a117811,
title = "Pancreatic cystic neuroendocrine tumors: Preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology",
abstract = "Pancreatic cystic neuroendocrine tumors (CNETs) are rare premalignant conditions. Computed tomography (CT) occasionally demonstrates the hypervascular border characteristic of NETs. Endoscopic ultrasound (EUS) with fine-needle aspiration and immunocytology may be a more consistent means to establish the diagnosis, but no data on the role of EUS are available. This report represents the largest series of CNETs treated to date, documents the role of EUS in preoperative diagnosis, and describes current management. Retrospective review of our experience with CNETs treated at an academic center between 1999 and 2006. Thirteen patients with CNETs were identified. One had symptoms consistent with a functional tumor; the others were nonfunctional. Twelve were detected by CT; only three had peripheral hypervascularity. Nine were studied with preoperative EUS/immunocytology; each of these demonstrated strong staining for chromogranin and synaptophysin. All were resected: four by pancreaticoduodenectomy, one by total pancreatectomy, and one by enucleation. Perioperative morbidity occurred in 39{\%}. Perioperative mortality was 0{\%}. Average follow-up was 3.3∈+∈0.5 years. One patient had late hepatic recurrence and ultimately died of disease. Two developed recurrent NET in the context of MEN I and required additional surgery. Twelve are alive with no evidence of disease. EUS-guided immunocytology with staining for neuroendocrine markers is an accurate method to establish the diagnosis of CNET preoperatively. Short- and long-term outcomes after resection are excellent.",
keywords = "Chromogranin, Neuroendocrine tumors, Pancreatic cyst, Synaptophysin",
author = "Baker, {Marshall S.} and Knuth, {Jamie L.} and John DeWitt and Julia Leblanc and Harvey Cramer and Thomas Howard and C. Schmidt and Lillemoe, {Keith D.} and Pitt, {Henry A.}",
year = "2008",
month = "3",
doi = "10.1007/s11605-007-0219-7",
language = "English",
volume = "12",
pages = "450--456",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Pancreatic cystic neuroendocrine tumors

T2 - Preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology

AU - Baker, Marshall S.

AU - Knuth, Jamie L.

AU - DeWitt, John

AU - Leblanc, Julia

AU - Cramer, Harvey

AU - Howard, Thomas

AU - Schmidt, C.

AU - Lillemoe, Keith D.

AU - Pitt, Henry A.

PY - 2008/3

Y1 - 2008/3

N2 - Pancreatic cystic neuroendocrine tumors (CNETs) are rare premalignant conditions. Computed tomography (CT) occasionally demonstrates the hypervascular border characteristic of NETs. Endoscopic ultrasound (EUS) with fine-needle aspiration and immunocytology may be a more consistent means to establish the diagnosis, but no data on the role of EUS are available. This report represents the largest series of CNETs treated to date, documents the role of EUS in preoperative diagnosis, and describes current management. Retrospective review of our experience with CNETs treated at an academic center between 1999 and 2006. Thirteen patients with CNETs were identified. One had symptoms consistent with a functional tumor; the others were nonfunctional. Twelve were detected by CT; only three had peripheral hypervascularity. Nine were studied with preoperative EUS/immunocytology; each of these demonstrated strong staining for chromogranin and synaptophysin. All were resected: four by pancreaticoduodenectomy, one by total pancreatectomy, and one by enucleation. Perioperative morbidity occurred in 39%. Perioperative mortality was 0%. Average follow-up was 3.3∈+∈0.5 years. One patient had late hepatic recurrence and ultimately died of disease. Two developed recurrent NET in the context of MEN I and required additional surgery. Twelve are alive with no evidence of disease. EUS-guided immunocytology with staining for neuroendocrine markers is an accurate method to establish the diagnosis of CNET preoperatively. Short- and long-term outcomes after resection are excellent.

AB - Pancreatic cystic neuroendocrine tumors (CNETs) are rare premalignant conditions. Computed tomography (CT) occasionally demonstrates the hypervascular border characteristic of NETs. Endoscopic ultrasound (EUS) with fine-needle aspiration and immunocytology may be a more consistent means to establish the diagnosis, but no data on the role of EUS are available. This report represents the largest series of CNETs treated to date, documents the role of EUS in preoperative diagnosis, and describes current management. Retrospective review of our experience with CNETs treated at an academic center between 1999 and 2006. Thirteen patients with CNETs were identified. One had symptoms consistent with a functional tumor; the others were nonfunctional. Twelve were detected by CT; only three had peripheral hypervascularity. Nine were studied with preoperative EUS/immunocytology; each of these demonstrated strong staining for chromogranin and synaptophysin. All were resected: four by pancreaticoduodenectomy, one by total pancreatectomy, and one by enucleation. Perioperative morbidity occurred in 39%. Perioperative mortality was 0%. Average follow-up was 3.3∈+∈0.5 years. One patient had late hepatic recurrence and ultimately died of disease. Two developed recurrent NET in the context of MEN I and required additional surgery. Twelve are alive with no evidence of disease. EUS-guided immunocytology with staining for neuroendocrine markers is an accurate method to establish the diagnosis of CNET preoperatively. Short- and long-term outcomes after resection are excellent.

KW - Chromogranin

KW - Neuroendocrine tumors

KW - Pancreatic cyst

KW - Synaptophysin

UR - http://www.scopus.com/inward/record.url?scp=39149101770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149101770&partnerID=8YFLogxK

U2 - 10.1007/s11605-007-0219-7

DO - 10.1007/s11605-007-0219-7

M3 - Article

C2 - 18157720

AN - SCOPUS:39149101770

VL - 12

SP - 450

EP - 456

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 3

ER -